Injective is trading at $7.72 with top traders sitting 58% net long and price holding above all major moving averages — a setup that puts $8.62 in play within 7–10 days if $7.84 resistance snaps. A...

Injective is sitting at $7.72 this morning, up nearly 2% in 24 hours, and trading comfortably above every meaningful moving average on the daily chart. That's not a minor detail — it means the multi-month structural trend is firmly pointing higher. Price is roughly $1.50 above the 50-day average and nearly $3 above the 200-day, which tells you this isn't a bounce off a floor; it's sustained trend participation.

What's happening in the broader Layer-1 and DeFi space matters here. INJ doesn't trade in a vacuum. When Bitcoin holds firm and risk appetite tilts toward smart-chain ecosystems, protocols with real DeFi throughput — like Injective — tend to see disproportionate inflows. Right now, that macro tailwind is alive, and Blockchain.news has been tracking the continued rotation into L1 DeFi plays as institutional desk activity picks back up heading into Q4 2026.

The 24-hour range of $7.43 to $7.75 tells another story, though: buyers are pushing, but conviction isn't explosive yet. INJ is pressing against its immediate resistance at $7.84 without having cracked it. The next 48 hours are the proving ground.

Here's where INJ gets interesting from a pure price structure standpoint. Momentum is flattening — not rolling over, but pausing — after a meaningful bullish run. The MACD histogram has compressed to essentially zero, which historically marks one of two outcomes: a consolidation that reloads before the next leg, or a slow bleed if sellers step in at resistance.

Source link